Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncogenesis|March 7, 2020
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1sMeirong Zang, Jiaojiao Guo, Lanting Liu, et al.
Oncotarget|September 30, 2015
Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISHMeirong Zang, Dehui Zou, Zhen Yu, et al.
Annals of Hematology|September 19, 2014
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patientsGang An, Xiaoqi Qin, Chirag Acharya, et al.
Experimental Hematology|December 3, 2014
Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatmentGang An, Chirag Acharya, Shuhui Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myelomaGang An, Zengjun Li, Yu-Tzu Tai, et al.
Pageof 2